effects of 15-deoxy-δ12,14-prostaglandin j2 (15d-pgj2) and rosiglitazone on human vδ2+ t cells15-deoxy-δ12、14-prostaglandin j2(15 d-pgj2)和罗格列酮对人类vδ2 + t细胞.pdfVIP

  • 10
  • 0
  • 约6.03万字
  • 约 8页
  • 2017-09-01 发布于上海
  • 举报

effects of 15-deoxy-δ12,14-prostaglandin j2 (15d-pgj2) and rosiglitazone on human vδ2+ t cells15-deoxy-δ12、14-prostaglandin j2(15 d-pgj2)和罗格列酮对人类vδ2 + t细胞.pdf

effectsof15-deoxy-δ12,14-prostaglandinj2(15d-pgj2)androsiglitazoneonhumanvδ2tcells15-deoxy-δ12、14-prostaglandinj2(15d-pgj2)和罗格列酮对人类vδ2t细胞

Effects of 15-Deoxy-D12,14-Prostaglandin J2 (15d-PGJ2) and Rosiglitazone on Human Vd2+ T Cells Haishan Li, C. David Pauza* Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, United States of America Abstract Background: Thiazolidinediones (TZD) class of drugs, and 15-deoxy-D12,14-prostaglandin J2 (15d-PGJ2) are immune regulators predicted to modulate human autoimmune disease. Their effects on cd T cells, which are involved in animal model and human and animal autoimmune dis

您可能关注的文档

文档评论(0)

1亿VIP精品文档

相关文档